Article Versions Notes

Petrakis I, Drosataki E, Stavrakaki I, Dermitzaki K, Lygerou D, Konidaki M, Pleros C, Kroustalakis N, Maragkou S, Androvitsanea A, et al. The p.Pro482Ala Variant in the CNNM2 Gene Causes Severe Hypomagnesemia Amenable to Treatment with Spironolactone. International Journal of Molecular Sciences. 2022; 23(13):7284. https://doi.org/10.3390/ijms23137284

Petrakis, Ioannis, Eleni Drosataki, Ioanna Stavrakaki, Kleio Dermitzaki, Dimitra Lygerou, Myrto Konidaki, Christos Pleros, Nikolaos Kroustalakis, Sevasti Maragkou, Ariadni Androvitsanea, and et al. 2022. "The p.Pro482Ala Variant in the CNNM2 Gene Causes Severe Hypomagnesemia Amenable to Treatment with Spironolactone" International Journal of Molecular Sciences 23, no. 13: 7284. https://doi.org/10.3390/ijms23137284

Petrakis, I., Drosataki, E., Stavrakaki, I., Dermitzaki, K., Lygerou, D., Konidaki, M., Pleros, C., Kroustalakis, N., Maragkou, S., Androvitsanea, A., Stylianou, I., Zaganas, I., & Stylianou, K. (2022). The p.Pro482Ala Variant in the CNNM2 Gene Causes Severe Hypomagnesemia Amenable to Treatment with Spironolactone. International Journal of Molecular Sciences, 23(13), 7284. https://doi.org/10.3390/ijms23137284